| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 6399 | 2013 |
| Comprehensive genomic characterization of head and neck squamous cell carcinomas Cancer Genome Atlas Network Nature 517 (7536), 576, 2015 | 3205 | 2015 |
| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2591 | 2014 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 175 (4), 998-1013. e20, 2018 | 1541 | 2018 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1523 | 2014 |
| Landscape of genomic alterations in cervical carcinomas AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, ... Nature 506 (7488), 371-375, 2014 | 820 | 2014 |
| Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ... Nature communications 8 (1), 1324, 2017 | 738 | 2017 |
| Characterization of HPV and host genome interactions in primary head and neck cancers M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ... Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014 | 412 | 2014 |
| Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis AL Astier, G Meiffren, S Freeman, DA Hafler The Journal of clinical investigation 116 (12), 3252-3257, 2006 | 352 | 2006 |
| Somatic mutation of CDKN1B in small intestine neuroendocrine tumors JM Francis, A Kiezun, AH Ramos, S Serra, CS Pedamallu, ZR Qian, ... Nature genetics 45 (12), 1483-1486, 2013 | 341 | 2013 |
| Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing SR Viswanathan, G Ha, AM Hoff, JA Wala, J Carrot-Zhang, CW Whelan, ... Cell 174 (2), 433-447. e19, 2018 | 318 | 2018 |
| Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ... Cancer discovery 8 (1), 37-48, 2018 | 271 | 2018 |
| Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies U Nayar, O Cohen, C Kapstad, MS Cuoco, AG Waks, SA Wander, ... Nature genetics 51 (2), 207-216, 2019 | 222 | 2019 |
| Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia L Wang, AN Brooks, J Fan, Y Wan, R Gambe, S Li, S Hergert, S Yin, ... Cancer cell 30 (5), 750-763, 2016 | 210 | 2016 |
| Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer DG Stover, HA Parsons, G Ha, SS Freeman, WT Barry, H Guo, ... Journal of Clinical Oncology 36 (6), 543, 2018 | 204 | 2018 |
| Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma S Manier, J Park, M Capelletti, M Bustoros, SS Freeman, G Ha, J Rhoades, ... Nature communications 9 (1), 1691, 2018 | 179 | 2018 |
| The cancer genome atlas expression subtypes stratify response to checkpoint inhibition in advanced urothelial cancer and identify a subset of patients with high survival … J Kim, D Kwiatkowski, DJ McConkey, JJ Meeks, SS Freeman, J Bellmunt, ... European urology 75 (6), 961-964, 2019 | 152 | 2019 |
| Genomic and immune profiling of pre-invasive lung adenocarcinoma H Chen, J Carrot-Zhang, Y Zhao, H Hu, SS Freeman, S Yu, G Ha, ... Nature communications 10 (1), 5472, 2019 | 144 | 2019 |
| Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ... Clinical Cancer Research 26 (11), 2556-2564, 2020 | 129 | 2020 |
| The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis X Hong, W Roh, RJ Sullivan, KHK Wong, BS Wittner, H Guo, TD Dubash, ... Cancer discovery 11 (3), 678-695, 2021 | 126 | 2021 |
